#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Penile squamous cell carcinoma Squamous cell carcinoma of the hypopharynx Oesophageal squamous cell carcinoma stage II Follicle centre lymphoma follicular grade I, II – III Monogenic diabetes Thermal burn Aspergillus infection Familial amyotrophic lateral sclerosis Progressive multifocal leukoencephalopathy Multifocal motor neuropathy Vulval cancer Acute graft versus host disease in skin Primary adrenal insufficiency Warm autoimmune haemolytic anaemia Hepatitis D More trials…

    Learn about Rare Diseases

    Chondrosarcoma – Diagnostics Rhabdomyosarcoma Primary hyperoxaluria – Basic Information Turner’s syndrome – Diagnostics Alveolar rhabdomyosarcoma – Basic Information Small intestine leiomyosarcoma – Basic Information Undifferentiated sarcoma – Life with Disease Urea cycle disorder Hereditary neuropathic amyloidosis – Diagnostics Congenital generalised lipodystrophy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Propranolol Gskvx000000009151 Plitidepsin Oregovomab Morf-057 Poa Pratensis Propranolol Hydrochloride Masitinib Prednisolone Sodium Succinate Ovolecithin ZINC Anv600 Lbl-007 Anifrolumab Propylene Glycol Vibostolimab SAT-3247 OXALATE YOHIMBINE HYDROCHLORIDE Wt1/Il15/Il15Ra Mrna Dc Blu-451 More therapies…

    Learn about Your Condition

    Metabolic syndrome Polyneuropathy Cystic fibrosis lung Premature baby Thrombosis Adenocarcinoma gastric Haematological infection Mantle cell lymphoma Lichen planopilaris Metastatic glioma Hypertrophic scar Right ventricular dysfunction Meningioma malignant Metastases to liver Diabetic gastroparesis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. InterHem Poradnie Specjalistyczne

InterHem Poradnie Specjalistyczne

Ul. Choroszczanska 24, Bialystok, 15-732, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myelofibrosis
    Investigated Drugs:
    • Loperamide Hydrochloride
    • Navtemadlin
    • Ondansetron
    Austria Belgium Croatia Czechia France Germany +7

  • Long-term Study of Zanubrutinib for Patients with B-cell Blood Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Zanubrutinib
    Czechia France Germany Greece Italy The Netherlands +3

  • Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Other Analgesics And Antipyretics
    • Secukinumab
    Denmark Greece Hungary Italy Poland Spain

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!